Depression Screening and Glycated Hemoglobin Levels: Diabetes Follow-Up Measures

2.50
Hdl Handle:
http://hdl.handle.net/10755/621577
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Depression Screening and Glycated Hemoglobin Levels: Diabetes Follow-Up Measures
Author(s):
McGhee, Kristel Rosemarie; Kenny, Katherine
Lead Author STTI Affiliation:
Non-member
Author Details:
Kristel Rosemarie McGhee, BSN, RN, CNRN, Professional Experience: Doctor of Nursing Practice student with an Adult-Gerontology Nurse Practitioner specialty, Arizona State University, Phoenix, AZ (2014-17) ASU NP clinical rotations at community internal medicine and endocrinology clinics, Phoenix & Scottsdale, AZ (2015-16) Registered Nurse on medical-surgical inpatient units, Summit, NJ & Phoenix, AZ (2011-17) Author Summary: Kristel McGhee is a DNP, Adult-Gerontology Nurse Practitioner student at Arizona State University, graduating May 2017. During clinical rotations at community internal medicine and endocrinology clinics, she cared for many diabetes patients who were distressed by their diabetes related complications. With a true passion for improving diabetes patient care outcomes and decreasing neurological complications, she decided to complete her final doctoral project on this patient population. She is also a certified neuroscience registered nurse.
Abstract:

Diabetes and depression often co-exist. This combination may exacerbate the progression of diabetes; therefore, diagnosis and treatment of depression may improve diabetes management. In addition to routine monitoring of glycated hemoglobin (A1C) levels, diabetic patients should receive an annual depression screen to facilitate treatment and referral. Yet in the outpatient setting, depression screening is an underutilized tool. The overarching purpose of this project is to address and treat the depression in patients with diabetes, and to decrease A1C levels and ultimately improve chronic disease outcomes.

A literature review explored interventions to improve chronic disease outcomes in adults. Selected studies revealed common themes that impacted outcomes in diabetic patients and included missed appointments, elevated A1C levels with co-existing depression, and missed depression diagnosis.

This project explored outcomes associated with implementation of scheduled depression screening for patients with diabetes age 18 to 64 in an urban community internal medicine clinic. All diabetic patients were screened with the Patient Health Questionnaire-9 (PHQ-9) at follow-up appointments over a 4-week period. Demographic data and the severity of depression measured by the PHQ-9 score will provide descriptive analysis of the screened populations. Measures of central tendency and spread will also be analyzed. The measurable outcomes include the following: number of diabetic patients who were not being treated for depression at the time they completed the questionnaire, and whose responses to the PHQ-9 would support a diagnosis of depression.

Consistent screening will support treatment and referral of diabetic patients whose PHQ-9 result indicates depression. This cost-effective intervention may reduce complications of diabetes, and help patients manage their A1C levels.

At community internal medicine practices internationally, there is room for improvement in diabetes follow-up care. Additional monitoring strategies may lessen emergency department visits and hospital readmission for all patients with diabetes. The goal is to identify these high-risk patients, screen for depression, and ensure follow-up care. Given the minimal effort and cost of depression screening, outpatient clinics internationally may consider routinely screening patients with diabetes for depression.

Keywords:
A1C; Diabetes; Depression Screening
Repository Posting Date:
22-Jun-2017
Date of Publication:
22-Jun-2017
Other Identifiers:
INRC17PST461
Conference Date:
2017
Conference Name:
28th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International
Conference Location:
Dublin, Ireland
Description:
Event Theme: Influencing Global Health Through the Advancement of Nursing Scholarship

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titleDepression Screening and Glycated Hemoglobin Levels: Diabetes Follow-Up Measuresen_US
dc.contributor.authorMcGhee, Kristel Rosemarieen
dc.contributor.authorKenny, Katherineen
dc.contributor.departmentNon-memberen
dc.author.detailsKristel Rosemarie McGhee, BSN, RN, CNRN, Professional Experience: Doctor of Nursing Practice student with an Adult-Gerontology Nurse Practitioner specialty, Arizona State University, Phoenix, AZ (2014-17) ASU NP clinical rotations at community internal medicine and endocrinology clinics, Phoenix & Scottsdale, AZ (2015-16) Registered Nurse on medical-surgical inpatient units, Summit, NJ & Phoenix, AZ (2011-17) Author Summary: Kristel McGhee is a DNP, Adult-Gerontology Nurse Practitioner student at Arizona State University, graduating May 2017. During clinical rotations at community internal medicine and endocrinology clinics, she cared for many diabetes patients who were distressed by their diabetes related complications. With a true passion for improving diabetes patient care outcomes and decreasing neurological complications, she decided to complete her final doctoral project on this patient population. She is also a certified neuroscience registered nurse.en
dc.identifier.urihttp://hdl.handle.net/10755/621577-
dc.description.abstract<p><span>Diabetes and depression often co-exist. This combination may exacerbate the progression of diabetes; therefore, diagnosis and treatment of depression may improve diabetes management. In addition to routine monitoring of glycated hemoglobin (A1C) levels, diabetic patients should receive an annual depression screen to facilitate treatment and referral. Yet in the outpatient setting, depression screening is an underutilized tool. The overarching purpose of this project is to address and treat the depression in patients with diabetes, and to decrease A1C levels and ultimately improve chronic disease outcomes.</span></p> <p>A literature review explored interventions to improve chronic disease outcomes in adults. Selected studies revealed common themes that impacted outcomes in diabetic patients and included missed appointments, elevated A1C levels with co-existing depression, and missed depression diagnosis.</p> <p>This project explored outcomes associated with implementation of scheduled depression screening for patients with diabetes age 18 to 64 in an urban community internal medicine clinic. All diabetic patients were screened with the Patient Health Questionnaire-9 (PHQ-9) at follow-up appointments over a 4-week period. Demographic data and the severity of depression measured by the PHQ-9 score will provide descriptive analysis of the screened populations. Measures of central tendency and spread will also be analyzed. The measurable outcomes include the following: number of diabetic patients who were not being treated for depression at the time they completed the questionnaire, and whose responses to the PHQ-9 would support a diagnosis of depression.</p> <p>Consistent screening will support treatment and referral of diabetic patients whose PHQ-9 result indicates depression. This cost-effective intervention may reduce complications of diabetes, and help patients manage their A1C levels.</p> <p>At community internal medicine practices internationally, there is room for improvement in diabetes follow-up care. Additional monitoring strategies may lessen emergency department visits and hospital readmission for all patients with diabetes. The goal is to identify these high-risk patients, screen for depression, and ensure follow-up care. Given the minimal effort and cost of depression screening, outpatient clinics internationally may consider routinely screening patients with diabetes for depression.</p>en
dc.subjectA1Cen
dc.subjectDiabetesen
dc.subjectDepression Screeningen
dc.date.available2017-06-22T14:47:39Z-
dc.date.issued2017-06-22-
dc.date.accessioned2017-06-22T14:47:39Z-
dc.conference.date2017en
dc.conference.name28th International Nursing Research Congressen
dc.conference.hostSigma Theta Tau Internationalen
dc.conference.locationDublin, Irelanden
dc.descriptionEvent Theme: Influencing Global Health Through the Advancement of Nursing Scholarshipen
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.